Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Rein Therapeutics Inc. (RNTX) had Free Cash Flow per Share of $-0.11 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-5.84M |
|
-- |
|
-- |
|
$5.23M |
|
$-5.23M |
|
$-0.61M |
|
$-5.84M |
|
$-5.84M |
|
$-5.84M |
|
$-5.84M |
|
$-5.84M |
|
$-5.84M |
|
$-5.23M |
|
$-4.61M |
|
30.36M |
|
30.36M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$5.45M |
|
-- |
|
$20.84M |
|
$26.29M |
|
$13.64M |
|
-- |
|
$46.06M |
|
$59.70M |
|
$-33.41M |
|
$-53.24M |
|
$-33.41M |
|
28.04M |
|
| Cash Flow Statement Financials | |
$-3.42M |
|
-- |
|
$4.65M |
|
$3.21M |
|
$4.45M |
|
$1.23M |
|
$0.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.40 |
|
-- |
|
-- |
|
-- |
|
-0.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.42M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
17.47% |
|
10.96% |
|
-22.21% |
|
17.47% |
|
$-1.19 |
|
|
Free Cash Flow per Share |
$-0.11 |
$-0.11 |
|